Expression of AQP5 and AQP8 in human colorectal carcinoma and their clinical significance
© Wang et al.; licensee BioMed Central Ltd. 2012
Received: 7 August 2012
Accepted: 31 October 2012
Published: 13 November 2012
The aquaporins (AQPs) are a family of small membrane transport proteins whose overexpression has been implicated in tumorigenesis. However, the expression of AQP5 and AQP8 in colorectal cancer and the clinical significance remain unexplored. This study aimed to detect the expression of AQP5 and AQP8 in clinical samples of colorectal cancer and analyze the correlations of their expression with the clinicopathological features of colorectal cancer.
Forty pairs of colorectal cancer tissue and paraneoplastic normal tissue were obtained at the time of surgery from patients with colorectal cancer. The expression of AQP5 and AQP8 was detected by immunohistochemical staining and reverse transcriptase polymerase chain reaction.
AQP5 was mainly expressed in colorectal carcinoma cells and barely expressed in paraneoplastic normal tissues. By contrast, AQP8 was mainly expressed in paraneoplastic normal tissues and barely expressed in colorectal carcinoma cells. AQP5 expression was not significantly associated with the sex or age of the patient with colorectal cancer (P>0.05), but was closely associated with the differentiation, tumor-nodes-metastasis stage and distant lymph node metastasis of colorectal carcinoma (P<0.05).
AQP5 might be a novel prognostic biomarker for patients with colorectal cancer.
Colorectal carcinoma (CRC) is one of the most common malignancies in the world. Despite the advances in the diagnosis and treatment of CRC in the past several years, the overall prognosis for patients with CRC remains poor. Therefore, many investigations have focused on the identification of novel prognostic and predictive biomarkers for CRC and a variety of biomarkers that could predict the survival of CRC have been reported recently[2–6].
It is well-known that tumor growth, development, invasion and metastasis depend on nutrient supply and metabolism and water molecules play an important role in the modulation of the tumor microenvironment and tumor metabolism. The aquaporins (AQPs) consist of a family of small membrane transport proteins. Up to now, 13 members of the AQPs have been identified in human, which can be subdivided into two groups based on the basis of their permeability: AQP1, 2, 4, 5 and 8 function primarily as water-selective transporters, while AQP3, 7, 9 and 10, termed aquaglyceroporins, transport water as well as glycerol and other small solutes. The overexpression of several members of the AQPs family has been shown to be implicated in tumorigenesis. For example, AQP5 is overexpressed in breast cancer, cervical cancer and ovarian cancer[8–10]. However, the expression of AQP5 and AQP8 in CRC and their clinical significance remain unexplored. To evaluate the potential of AQP5 and AQP8 as novel prognostic markers of CRC, we employed RT-PCR and immunohistochemical methods to detect the expression of AQP5 and AQP8 in clinical samples of CRC and then analyzed the correlations of their expression with the clinicopathological features of CRC.
Patients and tumor samples
From December 2009 to January 2011, samples were collected from 40 cases of CRC from the Department of Surgery, the First Affiliated Hospital of Liaoning Medical University. The clinical samples were obtained from surgically removed, pathologically confirmed CRC. The patients included 25 men and 15 women and their ages ranged from 35 to 80 years old. None of the patients accepted preoperative radiotherapy or chemotherapy and none of them had hypertension or diabetes. The pathological classifications of CRC were based on tumor size, infiltration, differentiation and lymph node metastasis. The matched non-tumor adjacent tissue was obtained from a segment of the resected specimens that was the farthest from the tumor (>3 cm). Tissue samples were snap-frozen in liquid nitrogen and stored at −80°C until further analysis. The collection of clinical samples was approved by the Ethics Committee of Liaoning Medical University, and all patients gave their written informed consent.
Tumor tissues and normal tissues were fixed in 10% formaldehyde and were paraffin wax-embedded. Subsequently, the tissues were cut into 5-μm-thick serial sections, which were washed carefully with 0.01 M PBS three times. To block endogenous peroxidases, de-waxed paraffin sections were treated with 3% hydrogen peroxide for 20 min. The sections were blocked with 2% goat serum in 0.01 M PBS containing 0.3% Triton X-100 for 1 h at room temperature, then incubated at 4°C overnight with rabbit antibody against human AQP5 (1:250 dilution, Bioss Inc., Beijing, China) or AQP8 (1:200 dilution, Bioss Inc.). Afterwards, the sections were subjected to immunohistochemical staining using PV6000 kit (Bioss Inc.). Finally the sections were developed with diaminobenzidine and assessed by two independent investigators under light microscopy. The staining was considered to be positive when a strong coloration was evident in the membranes of the epithelial cells. Tissues were scored semi-quantitatively by evaluating the percentage of stained cells of 10 separate fields. For negative controls, the primary antibodies were replaced with PBS.
Total RNA was extracted from the tissues (100 g) using Trizol (Invitrogen, Carlsbad, CA, USA) following the manufacturer's protocol. cDNA was produced by reverse transcription using an RT kit (Takara, Shiga, Japan) following the manufacturer's protocol. PCR amplification of AQP5, AQP8 and β-actin was done with Taq Master Mix(Promega, Madison, WI, USA)with cDNA synthesized from the tissues. The primers used were as follows: AQP5 5′-TGACGAGGACTGGGAGGAGC-3′ (forward) and 5′-GGCGGCATTCAATGAACCA-3′ (reverse), amplicon 488 bp; AQP8 5′-TCATTGGAGATGGGAAGACC-3′ (forward) and 5′-TGAGAAGCAAGGAAGTGGC-3′ (reverse), amplicon 437 bp; β-actin 5′-GTTCGCCATGGATGACGATATC-3′ (forward) and 5′-GCCAGATCTTCTCCATGTCGTC-3′ (reverse), amplicon 128 bp. Amplification conditions were as follows: 5 min at 95°C (one cycle) and 40 s at 94°C; 40 s at the annealing temperature (58.5°C for AQP5, 56.8°C for AQP8 and 58.8°C for β-actin); and 1 min at 72°C (35 cycles) and 72°C for 5 min (one cycle). PCR products were analyzed by 2% gel electrophoresis following densitometric analysis of band intensity. The relative mRNA levels of AQP5 and AQP8 were determined with β-actin as the internal control.
The data were expressed as mean (X) ± standard deviation (S). Statistical analysis was performed using SPSS13.0 software (SPSS, Inc., Chicago, IL, USA) and P <0.05 was considered significant.
The relationship of AQP5 expression with clinicopathological features of colorectal carcinoma
The relationship between AQP5 expression in colorectal carcinoma and clinicopathological features
High and medium
I + II
III + IV
Aquaporins play a crucial role in maintaining water homeostasis and glycerol metabolism and modulating a variety of physiological and pathological processes. Significantly, several members of the AQPs family are involved in tumorigenesis, as suggested by their overexpression in clinical cancer tissues and cancer cell lines[8–10].
AQP5 has been shown to be overexpressed in several types of cancers and contribute to tumor growth, progression and metastasis. Consequently, AQP5 has been proposed as a putative oncogene[11, 12]. Recently, Zhang et al. reported that AQP5 overexpression was significantly associated with lymph node involvement and a poorer prognosis in patients with cervical cancer, suggesting the value of AQP5 as a prognostic marker in cervical cancer. Interestingly, Fischer et al. performed differential display to find that AQP8 mRNA was expressed only in normal colonic tissue and not, or to a much lesser extent, in the adenomas, carcinomas and cancer cell lines. In situ hybridization demonstrated that AQP8 was expressed in the cells facing the lumen in the normal colonic epithelium.
The clinical significance of AQP5 and AQP8 in colorectal carcinoma remains largely unexplored. We employed RT-PCR and immunohistochemical methods to detect the expression of AQP5 and AQP8 in clinical samples of colorectal carcinoma and the paraneoplastic normal colonic tissues. Our results showed that AQP5 was mainly expressed in colorectal carcinoma cells and barely expressed in paraneoplastic normal tissues. By contrast, AQP8 was mainly expressed in paraneoplastic normal tissues and barely expressed in colorectal carcinoma cells. The expression patterns of AQP5 and AQP8 in colonic tissues we detected are consistent with the results of previous studies[13, 14]. Furthermore, we analyzed the correlations of AQP5 expression with the clinicopathological features of CRC and found that AQP5 expression was not significantly associated with the sex or age of patients with CRC (P>0.05), but was closely associated with the differentiation, TNM stage and distant lymph node metastasis of colorectal carcinoma (P<0.05). Taken together, our results demonstrate that AQP5 is upregulated and AQP8 is downregulated in CRC tissues.
It has been proposed that the expression of AQP8 is a marker of normal proliferating colonic epithelial cells and suggests these cells to be involved in fluid transport in the colon. Alternatively, in situ hybridization demonstrated that the expression of AQP5 was induced in early-stage disease (early dysplasia) and then maintained through the late stages of colon cancer development. Therefore, our observations that AQP8 expression was not detected in colorectal carcinoma while AQP5 expression was closely associated with the differentiation, TNM stage and distant lymph node metastasis of colorectal carcinoma suggest that the loss of AQP8 expression and gain of AQP5 expression is involved in the process of colorectal carcinogenesis.
Notably, it was reported recently that epigallocatechin gallate, a potential anticancer drug, inhibited the proliferation and induced the apoptosis of ovarian cancer SKOV3 cells through the downregulation of AQP5 expression. This study confirmed the overexpression of AQP5 in CRC and suggested that AQP5 may be a potential therapeutic target. Further studies are important to characterize the potential oncogenic role of AQP5 and antitumor role of AQP8 in CRC development. Larger samples should be examined to validate the value of AQP5 as a novel prognostic biomarker for patients with CRC.
AQP5 may be a novel prognostic biomarker for patients with colorectal carcinoma.
This study was supported by following grants: Fund from Department of Science and Technology of Liaoning Province (No. 2010225034) and Fund for Talented Teachers of Liaoning Province (No. LJQ2011091).
- Arnold D, Stein A: Personalized treatment of colorectal cancer. Onkologie. 2012, 35 (Suppl 1): 42-48.View ArticlePubMedGoogle Scholar
- Xi RC, Biao WS, Gang ZZ: Significant elevation of survivin and livin expression in human colorectal cancer: inverse correlation between expression and overall survival. Onkologie. 2011, 34: 428-432. 10.1159/000331132.View ArticlePubMedGoogle Scholar
- Li XD, Miao SY, Wang GL, Yang L, Shu YQ, Yin YM: Amphiregulin and epiregulin expression in colorectal carcinoma and the correlation with clinicopathological characteristics. Onkologie. 2010, 33: 353-358. 10.1159/000315380.View ArticlePubMedGoogle Scholar
- Wang F, Zhang P, Ma Y, Yang J, Moyer MP, Shi C, Peng J, Qin H: NIRF is frequently upregulated in colorectal cancer and its oncogenicity can be suppressed by let-7a microRNA. Cancer Lett. 2012, 314: 223-231. 10.1016/j.canlet.2011.09.033.View ArticlePubMedGoogle Scholar
- Liang QL, Li ZY, Chen GQ, Lai ZN, Wang BR, Huang J: Prognostic value of serum soluble Fas in patients with locally advanced unresectable rectal cancer receiving concurrent chemoradiotherapy. J Zhejiang Univ Sci B. 2010, 11: 912-917. 10.1631/jzus.B1000277.PubMed CentralView ArticlePubMedGoogle Scholar
- Liang QL, Wang BR, Li GH: DcR3 and survivin are highly expressed in colorectal carcinoma and closely correlated to its clinicopathologic parameters. J Zhejiang Univ Sci B. 2009, 10: 675-682. 10.1631/jzus.B0920077.PubMed CentralView ArticlePubMedGoogle Scholar
- Ishibashi K, Hara S, Kondo S: Aquaporin water channels in mammals. Clin Exp Nephrol. 2009, 13: 107-117. 10.1007/s10157-008-0118-6.View ArticlePubMedGoogle Scholar
- Jung HJ, Park JY, Jeon HS, Kwon TH: Aquaporin-5: a marker protein for proliferation and migration of human breast cancer cells. PLoS One. 2011, 6 (12): e28492-10.1371/journal.pone.0028492.PubMed CentralView ArticlePubMedGoogle Scholar
- Zhang T, Zhao C, Chen D, Zhou Z: Over expression of AQP5 in cervical cancer: correlation with clinic opathological features and prognosis. Med Oncol. 2012, 29: 1998-2004. 10.1007/s12032-011-0095-6.View ArticlePubMedGoogle Scholar
- Yang JH, Yu YQ, Yan CX: Localisation and expression of aquaporin subtypes in epithelial ovarian tumours. Histol Histopathol. 2011, 26: 1197-1205.PubMedGoogle Scholar
- Woo J, Lee J, Chae YK, Kim MS, Baek JH, Park JC, Park MJ, Smith IM, Trink B, Ratovitski E, Lee T, Park B, Jang SJ, Soria JC, Califano JA, Sidransky D, Moon C: Overexpression of AQP5, a putative oncogene, promotes cell growth and transformation. Cancer Lett. 2008, 264: 54-62. 10.1016/j.canlet.2008.01.029.PubMed CentralView ArticlePubMedGoogle Scholar
- Chae YK, Woo J, Kim MJ, Kang SK, Kim MS, Lee J, Lee SK, Gong G, Kim YH, Soria JC, Jang SJ, Sidransky D, Moon C: Expression of aquaporin 5 (AQP5) promotes tumor invasion in human non small cell lung cancer. PLoS One. 2008, 3: e2162-10.1371/journal.pone.0002162.PubMed CentralView ArticlePubMedGoogle Scholar
- Fischer H, Stenling R, Rubio C, Lindblom A: Differential expression of aquaporin 8 in human colonic epithelial cells and colorectal tumors. BMC Physio. 2001, 1: 1-10.1186/1472-6793-1-1.View ArticleGoogle Scholar
- Kang SK, Chae YK, Woo J, Kim MS, Park JC, Lee J, Soria JC, Jang SJ, Sidransky D, Moon C: Role of human aquaporin 5 in colorectal carcinogenesis. Am J Pathol. 2008, 173: 518-525. 10.2353/ajpath.2008.071198.PubMed CentralView ArticlePubMedGoogle Scholar
- Moon C, Soria JC, Jang SJ, Lee J, ObaidulHoque M, Sibony M, Trink B, Chang YS, Sidransky D, Mao L: Involvement of aquaporins in colorectal carcinogenesis. Oncogene. 2003, 22: 6699-6703. 10.1038/sj.onc.1206762.View ArticlePubMedGoogle Scholar
- Yan C, Yang J, Shen L, Chen X: Inhibitory effect of epigallocatechin gallate on ovarian cancer cell proliferation associated with aquaporin 5 expression. Arch Gynecol Obstet. 2012, 285: 459-467. 10.1007/s00404-011-1942-6.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.